OncoSec Medical Inc (ONCSQ)

[Waitforit53]

a conversation with Punit, Fri. Jan. 23
since this board sucks now, I though I would through it a bone in this desert of DD. It's not mine:

So, I spoke to Punit for about 45 minutes. I first started off apologizing to him if my emails come off rude and aggressive.

Topics:

1) Website: He is very aware that the website is not up to par and is very frustrated how it is constructed. He informed me that a new website is in the works and will be launched once regulatory requirements are met. Great, glad he sees the issue and apparently is on the way to addressing it

2) PRs: I asked about the sophistication of the wording of the PRs and he agrees that there needs to be change. They are trying to internalize this process and the corporate communication team will be working this out in the coming weeks.I also asked about the lack of PRs and articles and he told me that he does want to ONCS to be affiliated with other companies that use this strategy and end up having lawsuits like ADXS. That is why there is a lack of articles on Seeking Alpha, etc. He feels that too many manipulators can use these articles as an opportunity to coordinate a short attack, like ADXS. I had gotten this impression from him as well, though I did not ask it outright. I don't like pumping, I do like share price movements.

3) Up-list and RS: I asked about a potential r/s and up-list to the nasdaq. I expressed to him that this is a very important step in garnering institutional interest. He does not want to to do a r/s and up-list in weakness. He wants to do it around an event and a data release. He told me that he headed Inovio's first r/s and learned a great deal on when to do one and when not to do one. So a R/S may occur this year but will done in a time of momentum and strength. Same answer I got

4) Institutional Interest: I asked what is being done to gain institutional interest and he flatly told me that institutes do not care if your on the nasdaq or the OTC. They care about data and that is all. He wants to change the shareholder base to drive out retail investors and have a significant amount of institutions come in but this can only be done when there is more data releases.

5) Partnerships : He cannot comment on the relationship with Merck other what is already stated. I asked what can be done to get funded partnerships and he again reiterated that even though data was good last year, they need to show more evidence using PD1. He also stated that they have a head start due to the relationship already with Merck. Once more data read outs are released, this will attract more partnerships. He is not just waiting on Merck.

6) Insider buying: I asked why is there a lack of insider buying and he flatly told me that he if could buy shares today he would. But he is in possession with to much insider information and there are restrictions in place. Being an officer, he does want to mentioned with other biotech companies that use this strategy to boost share price. He feels there is a lot of scrutiny in the industry that use this strategy. He wants to focus on authenticity and make ONCS seem like a pump and dump. Figured, I got a very strong vibe that the P2 expanded melanoma data is going to be rather significant.

7) December capitulation: I asked why he felt the market did not respond to the data/good news well in December and he feels that investors ( short term traders) took advantage of the volume and liquidity for trading opportunities. He stated many stop losses probably occurred which caused the stock price to fall even further. He is very frustrated with that action and one of the reasons he wants to change the shareholder base. He says many investors follow the sheep mentality and are impatient.

8) Dilution: he flatly told me that he does want to dilute, and he can raise the cash anytime..not sure what he exactly meant by that. But he stated that they have cash runaway till the end of 2016. He said more dilution doesn't necessarily mean they are failing.
I I suspect that what he means is that if he wanted to dilute for another 250m shares he has an institution that is willing to buy them (slight exaggeration)

I'm sure there are more things I missed out, but I skipped lunch to talk to him and my brain is collapsing lol. Will add later...

Conclusion: Punit is cool guy and very personable. I personally feel like an asshole after constantly berating him on here. He is one of us. He stated that he put his life savings in this company and had to raise 1.1 million from his family. Its like his "baby". He actually enjoys getting emails from us and wouldn't mind speaking to anyone else who has the same concerns. That is the same impression I had, though did not realize he had that much at risk. He really seems like a very protective proud papa.